MedPath

Cinical study of Qinggan Jiangzhi Decoction Combined with external therapy of traditional Chinese medicine in the treatment of metabolic fatty liver disease

Not Applicable
Recruiting
Conditions
Fatty liver disease
Registration Number
ITMCTR2000003904
Lead Sponsor
Shanghai Hospital of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The patients who meet the diagnostic criteria of Western medicine, and the syndrome of spleen deficiency, phlegm and blood stasis is in accordance with the syndrome differentiation of traditional Chinese medicine;
2. Patients who are willing to cooperate with this study protocol should sign informed consent, aged 18-70 years.

Exclusion Criteria

1. Patients who fail to take medicine and observe according to regulations,
2. Patients who discontinue treatment due to non drug factors,
3. Patients who cannot judge the curative effect,
4. Patients with incomplete data affecting the efficacy and safety judgment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alanine aminotransferase;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath